Your browser doesn't support javascript.
loading
B cell immune response to human bocaviruses.
Karaaslan, Cagatay; Wirz, Oliver; Tan, Ge; Globinska, Anna; Boonpiyathad, Tadech; Hedman, Klaus; Vaselek, Slavica; Venermo, Maria Söderlund; Jartti, Tuomas; Akdis, Mubeccel; Akdis, Cezmi A.
Afiliação
  • Karaaslan C; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Wirz O; Molecular Biology Section, Biology Department, Faculty of Science, Hacettepe University, Ankara, Turkey.
  • Tan G; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Globinska A; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Boonpiyathad T; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Hedman K; Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
  • Vaselek S; Department of Virology, University of Helsinki, Helsinki, Finland.
  • Venermo MS; Helsinki University Hospital Diagnostics Center, Helsinki, Finland.
  • Jartti T; Molecular Biology Section, Biology Department, Faculty of Science, Hacettepe University, Ankara, Turkey.
  • Akdis M; Department of Virology, University of Helsinki, Helsinki, Finland.
  • Akdis CA; Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.
Clin Exp Allergy ; 54(6): 388-401, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38321724
ABSTRACT

BACKGROUND:

Human bocaviruses (HBoVs) have been demonstrated in respiratory and gastrointestinal infections; however, the immune response to them has not been studied in detail. In this study, we investigated the B cell immune responses to HBoV1 and HBoV2, representing two different species of bocaviruses in humans.

METHODS:

We analyzed the effects of stimulations with HBoV1 and 2 virus-like particles (VLPs) and of co-stimulation with HBoV1-rhinovirus (RV) on cells of the immune system by flow cytometry, transcriptomics, and luminometric immune assays.

RESULTS:

Human B cells, and particularly B regulatory cells (Breg cells), showed an increased immune response to HBoV1-VLPs stimulation. These immune responses were also supported by increased IL-1RA and PDL1 expressions in IL-10+ B cells from peripheral blood mononuclear cells (PBMCs) stimulated with HBoV1-VLPs. In addition, increased levels of IL-10 and IL-1RA were determined in the supernatants of PBMCs following HBoV1-VLPs stimulation. HBoV1-VLPs and RV co-stimulation increased the IL-10+ B cell population. Transcriptome analysis by next-generation RNA sequencing showed an increased expression of IL-10 signalling and Breg cell markers in PBMCs stimulated with HBoV1-VLPs. Furthermore, TGF-ß and chemoattractants MIP-1α, MIP-1ß and IP10 protein levels were high in the supernatants of PBMCs stimulated with HBoV1-VLPs.

CONCLUSIONS:

The findings demonstrate that in Breg cells, IL-10 signalling pathways, and anti-inflammatory activity are induced by HBoV1, which can explain the often mild nature of the disease. In addition, the immune regulatory response induced by HBoV1-VLPs may indicate a potential immunomodulatory role of HBoV1 on the immune system and may represent an immune regulatory strategy.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Bocavirus Humano Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Bocavirus Humano Idioma: En Ano de publicação: 2024 Tipo de documento: Article